<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 29, 1999
-----------------
CORAM HEALTHCARE CORPORATION
--------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 1-11343 33-0615337
- --------------- ------------ -------------------
(State or Other (Commission (IRS Employer
Jurisdiction of File Number) Identification No.)
Incorporation)
1125 Seventeenth Street, Suite 2100, Denver, Colorado 80202
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(303) 292-4973
----------------------------------------------------
(Registrant's telephone number, including area code)
<PAGE> 2
Item 5. Other Events.
On October 29, 1999, Coram Healthcare Corporation (the "Company")
issued a press release relating to the departure of Richard M. Smith as Chief
Executive Officer and President and the return of Donald J. Amaral, the
Company's Chairman of the Board, as interim Chief Executive Officer. The press
release is attached hereto as Exhibit 99.1 and is incorporated herein by
reference.
Item 7. Financial Statements and Exhibits.
(a) None.
(b) None.
(c) Exhibits.
99.1 Press Release, issued October 29, 1999, relating to
the resignation of Richard M. Smith as Chief
Executive Officer and the return of Donald J. Amaral,
the Company's Chairman of the board and former Chief
Executive Officer, as Chief Executive Officer on an
interim basis.
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CORAM HEALTHCARE CORPORATION
By: /s/ Wendy L. Simpson
------------------------------
Wendy L. Simpson
Executive Vice President and
Chief Financial Officer
Date: November 9, 1999
<PAGE> 4
EXHIBIT INDEX
99.1 Press Release, issued October 29, 1999, relating to the departure of
Richard M. Smith as Chief Executive Officer and President and the return of
Donald J. Amaral, the Company's Chairman of the Board, as interim Chief
Executive Officer.
<PAGE> 1
EXHIBIT 99.1
DON AMARAL TO SERVE AS INTERIM CHIEF EXECUTIVE OFFICER
DENVER, COLORADO, October 29, 1999 - Coram Healthcare Corporation (NYSE: CRH)
today announced that Donald J. Amaral, the Company's Chairman of the Board and
former Chief Executive Officer, will return as the Company's Chief Executive
Officer on an interim basis as the Company searches for a new Chief Executive
Officer following the departure of Richard M. Smith. "We are grateful for Rick
Smith's hard work and dedication to the Company during his tenure with us and
wish him well in his future endeavors," commented Mr. Amaral.
Denver based Coram Healthcare is a leading provider of high-quality home
infusion therapy operating from approximately 88 locations in 44 states and
Ontario, Canada. Coram Prescription Services (CPS) provides pharmacy benefit
management services as well as mail order prescription drugs for chronically ill
patients. The Clinical Research and Medical Informatics Division provides home
care and product development services to pharmaceutical, biotechnology and
medical device companies sponsoring clinical trials. These include specialized
alternate site services such as drug administration, education, patient
assessments, study coordination and data collection.
For more information, please visit the Company's web site at
www.coramhealthcare.com.
Note: Except for historical information, all other statements provided in this
press release are "forward-looking" within the meaning of the Private Securities
Litigation Reform Act of 1995. The Company's actual results may vary materially
from the forward-looking statements made above due to important factors such as
the Company's history of operating losses and uncertainties associated with
future operating results; significant outstanding indebtedness; equity
conversion rights held by existing debt holders; limited liquidity;
reimbursement-related risks; shifts in the mix of parties that pay for the
Company's services; dependence upon relationships with third parties; uncertain
future liabilities under capitation arrangements; concentration of large payors;
the intensely competitive industry; the timing of or ability to complete
acquisitions; government regulation of the home health care industry; certain
legal proceedings; dependence on key personnel; recruitment and retention of
trained personnel; potential volatility of stock price; New York Stock Exchange
listing status; and unanticipated impacts from the Year 2000 issue. These and
other risk factors that could affect Coram's financial results are further
described in the Company's Form 10-K Annual Report, as amended, Form 10-Q
Quarterly Reports, and Form 8-K Current Reports on file with the Securities and
Exchange Commission.
